So far, studies show GLP-1s may reduce alcohol consumption and drug use, and that there is no difference in risk of suicide or self-harm
Both BRICS countries reflect surging diabetic and pre-diabetic populations, growing retail interest in peptide-based interventions, and expanding domestic supplement manufacturing
Smeland OB, Meisingset TW, Borges K, Sonnewald U
Dietrich Bsselberg, January 2023-Current) from the Qatar National Research Fund (QNRF, a member of Qatar Foundation)
Recent post mortem studies revealed that GLP-1R expression was downregulated in the dorsal lateral prefrontal cortex and hippocampus of patients suffering from mood disorders, and those changes further correlated with an elevated body mass index (BMI) [79]